Galmed Pharmaceuticals Invests in Digital Assets: New Strategy Allocates Funds

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) has taken a bold step forward by adopting a new digital asset management strategy. The company’s board of directors has officially approved this plan as part of a revised financial investment policy and capital allocation framework. This new strategy will be overseen by a dedicated cryptocurrency committee, which will evaluate and manage activities surrounding crypto investments. The committee may allocate up to 50% of the company’s current cash reserves, estimated at $10 million, towards acquiring digital assets as part of this strategy.